Correlation Between Aileron Therapeutics and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both Aileron Therapeutics and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aileron Therapeutics and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aileron Therapeutics and Transcode Therapeutics, you can compare the effects of market volatilities on Aileron Therapeutics and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aileron Therapeutics with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aileron Therapeutics and Transcode Therapeutics.
Diversification Opportunities for Aileron Therapeutics and Transcode Therapeutics
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Aileron and Transcode is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Aileron Therapeutics and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Aileron Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aileron Therapeutics are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Aileron Therapeutics i.e., Aileron Therapeutics and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between Aileron Therapeutics and Transcode Therapeutics
Given the investment horizon of 90 days Aileron Therapeutics is expected to generate 1.25 times more return on investment than Transcode Therapeutics. However, Aileron Therapeutics is 1.25 times more volatile than Transcode Therapeutics. It trades about 0.18 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 187.00 in Aileron Therapeutics on October 22, 2024 and sell it today you would earn a total of 24.00 from holding Aileron Therapeutics or generate 12.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 68.42% |
| Values | Daily Returns |
Aileron Therapeutics vs. Transcode Therapeutics
Performance |
| Timeline |
| Aileron Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Transcode Therapeutics |
Aileron Therapeutics and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aileron Therapeutics and Transcode Therapeutics
The main advantage of trading using opposite Aileron Therapeutics and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aileron Therapeutics position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.| Aileron Therapeutics vs. Bio Path Holdings | Aileron Therapeutics vs. Benitec Biopharma Ltd | Aileron Therapeutics vs. Artelo Biosciences | Aileron Therapeutics vs. Curis Inc |
| Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |